We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Food can transmit infections when handled or stored incorrectly. To avoid this, make sure to take the following precautions:
Some foods may be carriers for bacteria or fungi, so try to avoid them temporarily.
In the first few days, we do not recommend eating raw salads and vegetables. After an initial visit to the doctor, if the doctor allows it, they will recommend the measures to be taken.
Skin care and hygiene
Related pathology: paediatric sarcomas, extraocular tumours of childhood, intraocular tumours of childhood, orbital tumours, neuroblastomas, blood stem cell transplant.
The advice below will help patients who have had external ear reconstruction surgery to recover:
Les persones amb insuficiència renal que entren en programa d'hemodiàlisi tenen una funció inferior al 10% de la funció normal. Amb xifres superiors de funció, generalment no és necessària l'hemodiàlisi.Cal practicar l'hemodiàlisi de forma periòdica, en sessions d'unes quatre hores i generalment tres cops per setmana, tot i que la durada i la freqüència depenen de cada pacient i de cada circumstància.El fonament de l'hemodiàlisi és biofísic, en el sentit que la sang quan passa per un filtre, intercanvia substàncies amb el líquid que hi ha present a l'altra banda del filtre i que és mogut en circulació per una màquina. Per a l'intercanvi, la sang s'allibera de la urea, del potassi, del fòsfor, i de diferents substàncies que s'acumulen pel dèficit del funcionament renal. El pas de les substàncies a través de la membrana es fa en part espontàniament, per què hi ha diferents concentracions de les diferents substàncies i la tendència és a igualar-se, i també per mitjà de canvis en la pressió que exerceix la màquina d'hemodiàlisi.Possibles complicacions de l'hemodiàlisi, són la infecció del catèter o l'esgotament dels accessos vasculars en pacients que estan durant anys amb hemodiàlisi.Tot que l'hemodiàlisi pot durar anys, generalment és un pas intermedi entre la insuficiència renal i el trasplantament.
We promote day surgery as it is an increasingly common alternative to traditional hospital admissions and is more convenient for patients. The facilities, technology and running of the whole centre are focused on maximising this kind of walk-in surgery.
How to get there
Vall d’Hebron’s Day Surgery Unit (UCSI), currently situated in the Pere Virgili Major Outpatient Surgery and Rehabilitation Centre, offers an alternative to the usual hospital admissions process. The 2,330 m2 Unit boasts the latest cutting edge technology, and facilities designed specifically with ambulatory surgery in mind. The centre has 6 operating rooms, 3 surgeon’s offices and 4 outpatient rooms for nursing, anaesthesia and surgical specialities. The unit currently performs over 13,700 procedures a year.
Whilst always under supervision, all patients can return home to continue their recovery a few hours after treatment. This surgery service is focused on convenience for patients, so they can recover in their normal environment without having to be admitted to hospital.
The surgical teams at the Day Surgery Unit come from other departments and units at Vall d’Hebron. Ambulatory surgery related to various parts of the Hospital is currently carried out here, such as General and Digestive Surgery, Maxillofacial Surgery, Dermatology, Ophthalmology, Otolaryngology, Urology and Vascular Surgery from the General Hospital; Orthopaedic foot, ankle, hand, shoulder and knee surgery, and Plastic and Reconstructive Surgery from the Traumatology, Rehabilitation and Burns Hospital; and Gynaecological Surgery, Fertility and Breast Disorder Surgery from the Maternity and Children’s Hospital.
The Day Surgery Unit also actively participates in specialised medical training through the Resident Medical Intern (MIR) programme in the different surgical specialisations.
The Paediatric Neurology Department at the Hospital Vall d’Hebron is specialised in the genetic diagnosis of childhood neurological diseases. It participates in different national and European reference networks (like the URDCat Project, Solve-RD, and the European Reference Network for Rare Neurological Diseases), which centralises a large number of paediatric patients with hereditary dystonia.
The genetic studies are carried out in the Paediatric Neurology Laboratory as part of several different research studies, which are funded by national and international entities as well as associations of families affected by dystonia.
Patients who are likely to suffer from dystonia undergo different metabolic, neurophysiological, and neuroimaging tests in order to classify what kind of dystonia they have, before carrying out genetic studies. Next, DNA sequencing studies are performed to establish the genetic origin of the dystonia.
There are many different genetic origins of dystonia. Therefore, diagnosing it requires both conventional and newly developed DNA sequencing techniques.
For patients with myoclonus-dystonia, first, Sanger sequencing is done for the epsilon-sarcoglycan gene, which is responsible for 70% of myoclonus-dystonia cases in children.
For patients with other kinds of dystonia, whole-exome sequencing (on the parents and the patient) or sequencing for the index case (the patient) is done first, depending on the DNA samples available.
To determine the origin of the patient’s dystonia, which is essential for deciding on a correct course of treatment.
There are no risks for the patient.
Skin tests are the technique most commonly used to begin diagnosing an allergy. Following a meticulous clinical history, it is decided which skin tests may be useful, depending on the case.
Skin allergy tests serve to find out if a patient is sensitised to a particular substance, if their body recognises the substance and reacts when it comes into contact with it. These tests do not diagnose an allergy. They are only positive if accompanied by one of the symptoms compatible with an allergy, helping a diagnosis to be reached.
There are two main types:
The risk of these tests is very low. Only in extremely allergic patients and usually with drug testing, there is a certain risk of serious and widespread allergic reaction.
In some cases, blood tests can be conducted to assess blood sensitisation.
Analytical testing provides a lot of information which enables the origin and severity of the kidney disease to be established. A kidney biopsy allows a microscopic study that is often essential. Genetic testing also provides very important information.
These tests serve to determine the origin of the kidney disease. There are many causes that may be genetic or acquired via a bacterial or viral infection, or resulting from a metabolic disease (diabetes) or an autoimmune disease such as lupus.
In addition to blood and urine tests, a kidney biopsy and/or a genetic analysis, imaging tests can also be useful.
A kidney biopsy may produce minimal bleeding that almost always stops by itself. If it doesn't, it can be controlled using an interventional radiology procedure, whereby the kidney is catheterised to close the area of bleeding. Genetic testing is increasingly used to decrease the need for a kidney biopsy. However, kidney biopsy continues to be the main diagnostic method for kidney disease.
The aim of the electrocardiogram is to determine any damage to the heart and the effects of medication and devices on the circulatory system’s main organ, as well as being very useful in detecting and analysing cardiac arrhythmias, acute episodes of coronary artery disease and myocardial infarction.
To perform the test, the healthcare professional attaches the electrocardiograph cables to the patient’s skin using adhesive patches or suction cups called “electrodes,” which are placed on the ankles, wrists, and chest to record the electrical impulses from different parts of the body.
During the electrocardiogram, the patient should lie down, stay relaxed, remain silent, breathe normally, and keep arms and legs still. Sometimes, the doctor may ask the patient to hold their breath for a few seconds.
The electrocardiograph records the heart’s electrical activity from the surface of the body using the attached electrodes. This recording is printed on paper and must be interpreted by a healthcare professional based on the patient’s symptoms and medical history.
It can also be used in preoperative evaluations, especially for surgeries of medium or high complexity, if risk factors are present, such as ischemic heart disease, diabetes, stroke, heart failure, or kidney dysfunction.
This is a simple and quick test that does not cause any discomfort or pain. In addition, it poses no risk to patients.
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.